
5-phenylthieno[2,3-d]pyrimidin-4-amine
CAS No. 195193-10-3
5-phenylthieno[2,3-d]pyrimidin-4-amine( —— )
Catalog No. M28408 CAS No. 195193-10-3
5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 57 | Get Quote |
![]() ![]() |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 131 | Get Quote |
![]() ![]() |
25MG | 224 | Get Quote |
![]() ![]() |
50MG | 336 | Get Quote |
![]() ![]() |
100MG | 503 | Get Quote |
![]() ![]() |
500MG | 1107 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name5-phenylthieno[2,3-d]pyrimidin-4-amine
-
NoteResearch use only, not for human use.
-
Brief Description5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
-
Description5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetALK
-
RecptorRARγ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number195193-10-3
-
Formula Weight227.285
-
Molecular FormulaC12H9N3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1ncnc2scc(-c3ccccc3)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M I Dawson, et al. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition. Int J Cancer. 2001 Jan 1;91(1):8-21.
molnova catalog



related products
-
ALK-IN-27
Neladalkib (NVL-655) is a selective and brain-permeable ALK inhibitor with antitumor activity that inhibits a variety of ALK-mutant oncoproteins, and may be useful in the study of non-small cell cancers.
-
LDN193189
LDN193189 is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM.
-
Lu AF21934
Lu AF21934 is a brain-penetrant and selective mGlu4 receptor positive allosteric modulator (IC50: 500 nM, human).